A5042123328- Antiplatelet Therapy and Cardiovascular Diseases
- Venous Thromboembolism Diagnosis and Management
- Connective tissue disorders research
- Diabetic Foot Ulcer Assessment and Management
- Schizophrenia research and treatment
- Neonatal Respiratory Health Research
- Balance, Gait, and Falls Prevention
- Primary Care and Health Outcomes
- Gastroesophageal reflux and treatments
- Vasculitis and related conditions
- Health Policy Implementation Science
- Heparin-Induced Thrombocytopenia and Thrombosis
- Pain Management and Opioid Use
- Inflammasome and immune disorders
- Gastrointestinal motility and disorders
- Rheumatoid Arthritis Research and Therapies
- Retinopathy of Prematurity Studies
- Oral health in cancer treatment
- Ethics in medical practice
- Syphilis Diagnosis and Treatment
- Mental Health and Patient Involvement
- Acute Ischemic Stroke Management
- Cancer, Stress, Anesthesia, and Immune Response
NHS Greater Glasgow and Clyde
2023
British Heart Foundation
2017
Leeds Teaching Hospitals NHS Trust
2017
Leeds General Infirmary
2017
Wellington Hospital
2017
University of Otago
2017
Nottingham City Hospital
2017
University of Nottingham
2017
Center for Pain and the Brain
2012
Balboa Nephrology Medical Group
2008
ObjectiveTo characterize the long-term safety and tolerability of brexpiprazole, an atypical antipsychotic, as maintenance treatment in adolescents with schizophrenia.MethodThis was interim analysis ongoing, 24-month, multicenter, single-arm, open-label, outpatient study oral brexpiprazole 1–4 mg/day (flexible dose) patients aged 13–17 years schizophrenia. Primary endpoints were incidence treatment-emergent adverse events (TEAEs), TEAEs by severity, serious TEAEs, (AEs) leading to...
This feasibility study aimed to investigate the of collecting and analysing tear proteins from preterm infants at risk retinopathy prematurity (ROP). Additionally, we sought identify any which might be implicated in pathophysiology ROP.Eligible were those undergoing ROP screening without other ocular pathology. Tear samples obtained by Schirmer's test strips coincident with routine screening. Mass spectrometry was used for proteomic analysis. All participants' parents gave written, informed...
The M I E gait analysis system has been developed to allow a range of objective measurements be readily obtained in clinical setting. equipment and its use are described together with series repeatability studies. results suggest that the is easy operate sufficiently reliable for departments.